U24HG006620
Cooperative Agreement
Overview
Grant Description
Democratization of Data Analysis in Life Sciences through Galaxy - Project Summary
For over a decade, the Galaxy Project (https://galaxyproject.org/) has worked to solve key issues plaguing modern data intensive biology. These issues include the ability of researchers to access cutting-edge analysis methods, to share analysis results transparently, and to precisely reproduce complex computational analyses. Galaxy has become one of the largest and most widely used open source platforms for biological data science.
Promoting openness and collaboration in all facets of the project, from technical decisions to training and leadership, has enabled us to build a vibrant community of users, developers, system engineers, and educators. This community continuously contributes new software features, adds the latest tools, adopts the most modern infrastructure, authors training materials, and leads research and training workshops.
Genomics research is continuously evolving, and current challenges include the rapid growth in size and complexity of new datasets, the increasing availability of controlled-access datasets with human genomic components, and the continuing expansion in the breadth of research areas capable of generating high throughput data.
The core Galaxy development team submitting this proposal will respond to these challenges by focusing on the following key priorities:
1. Re-architect Galaxy for scalability and security using software container technologies.
2. Design a new user interface (UI) for working with thousands of tools, workflows, and samples.
3. Enable interactive exploratory data analysis in Galaxy.
4. Facilitate community growth and support.
5. Enable effective training and outreach.
Concentrating on these broad priorities will allow us to achieve the ultimate goal of the Galaxy Project: developing a data analysis medium connecting biomedical experts across the full spectrum of skill sets, scientific domains, and research practices.
For biomedical researchers, Galaxy will provide a powerful analysis platform populated with the latest tools and data. For tool developers, it will provide a community-supported mechanism for deploying tools before a wide audience of users. For system administrators and engineers, it will provide a framework they will feel comfortable deploying on any infrastructure. For educators, it will provide a comprehensive collection of materials covering most data analysis needs and an infrastructure for delivering interactive, hands-on training workshops for audiences of different sizes.
For over a decade, the Galaxy Project (https://galaxyproject.org/) has worked to solve key issues plaguing modern data intensive biology. These issues include the ability of researchers to access cutting-edge analysis methods, to share analysis results transparently, and to precisely reproduce complex computational analyses. Galaxy has become one of the largest and most widely used open source platforms for biological data science.
Promoting openness and collaboration in all facets of the project, from technical decisions to training and leadership, has enabled us to build a vibrant community of users, developers, system engineers, and educators. This community continuously contributes new software features, adds the latest tools, adopts the most modern infrastructure, authors training materials, and leads research and training workshops.
Genomics research is continuously evolving, and current challenges include the rapid growth in size and complexity of new datasets, the increasing availability of controlled-access datasets with human genomic components, and the continuing expansion in the breadth of research areas capable of generating high throughput data.
The core Galaxy development team submitting this proposal will respond to these challenges by focusing on the following key priorities:
1. Re-architect Galaxy for scalability and security using software container technologies.
2. Design a new user interface (UI) for working with thousands of tools, workflows, and samples.
3. Enable interactive exploratory data analysis in Galaxy.
4. Facilitate community growth and support.
5. Enable effective training and outreach.
Concentrating on these broad priorities will allow us to achieve the ultimate goal of the Galaxy Project: developing a data analysis medium connecting biomedical experts across the full spectrum of skill sets, scientific domains, and research practices.
For biomedical researchers, Galaxy will provide a powerful analysis platform populated with the latest tools and data. For tool developers, it will provide a community-supported mechanism for deploying tools before a wide audience of users. For system administrators and engineers, it will provide a framework they will feel comfortable deploying on any infrastructure. For educators, it will provide a comprehensive collection of materials covering most data analysis needs and an infrastructure for delivering interactive, hands-on training workshops for audiences of different sizes.
Funding Goals
NHGRI SUPPORTS THE DEVELOPMENT OF RESOURCES AND TECHNOLOGIES THAT WILL ACCELERATE GENOME RESEARCH AND ITS APPLICATION TO HUMAN HEALTH AND GENOMIC MEDICINE. A CRITICAL PART OF THE NHGRI MISSION CONTINUES TO BE THE STUDY OF THE ETHICAL, LEGAL AND SOCIAL IMPLICATIONS (ELSI) OF GENOME RESEARCH. NHGRI ALSO SUPPORTS THE TRAINING AND CAREER DEVELOPMENT OF INVESTIGATORS AND THE DISSEMINATION OF GENOME INFORMATION TO THE PUBLIC AND TO HEALTH PROFESSIONALS. THE SMALL BUSINESS INNOVATION RESEARCH (SBIR) PROGRAM IS USED TO INCREASE PRIVATE SECTOR COMMERCIALIZATION OF INNOVATIONS DERIVED FROM FEDERAL RESEARCH AND DEVELOPMENT, TO INCREASE SMALL BUSINESS PARTICIPATION IN FEDERAL RESEARCH AND DEVELOPMENT, AND TO FOSTER AND ENCOURAGE PARTICIPATION OF SOCIALLY AND ECONOMICALLY DISADVANTAGED SMALL BUSINESS CONCERNS AND WOMEN-OWNED SMALL BUSINESS CONCERNS IN TECHNOLOGICAL INNOVATION. THE SMALL BUSINESS TECHNOLOGY TRANSFER (STTR) PROGRAM IS USED TO FOSTER SCIENTIFIC AND TECHNOLOGICAL INNOVATION THROUGH COOPERATIVE RESEARCH AND DEVELOPMENT CARRIED OUT BETWEEN SMALL BUSINESS CONCERNS AND RESEARCH INSTITUTIONS, TO FOSTER TECHNOLOGY TRANSFER BETWEEN SMALL BUSINESS CONCERNS AND RESEARCH INSTITUTIONS, TO INCREASE PRIVATE SECTOR COMMERCIALIZATION OF INNOVATIONS DERIVED FROM FEDERAL RESEARCH AND DEVELOPMENT, AND TO FOSTER AND ENCOURAGE PARTICIPATION OF SOCIALLY AND ECONOMICALLY DISADVANTAGED SMALL BUSINESS CONCERNS AND WOMEN-OWNED SMALL BUSINESS CONCERNS IN TECHNOLOGICAL INNOVATION.
Grant Program (CFDA)
Awarding / Funding Agency
Place of Performance
University Park,
Pennsylvania
16802
United States
Geographic Scope
Single Zip Code
Related Opportunity
Analysis Notes
Amendment Since initial award the total obligations have increased 347% from $1,910,000 to $8,539,654.
The Pennsylvania State University was awarded
Democratization of Data Analysis in Life Sciences Through Galaxy
Cooperative Agreement U24HG006620
worth $8,539,654
from National Human Genome Research Institute in February 2012 with work to be completed primarily in University Park Pennsylvania United States.
The grant
has a duration of 14 years and
was awarded through assistance program 93.172 Human Genome Research.
The Cooperative Agreement was awarded through grant opportunity Genomic Community Resources (U24).
Status
(Ongoing)
Last Modified 5/5/25
Period of Performance
2/19/12
Start Date
1/31/26
End Date
Funding Split
$8.5M
Federal Obligation
$0.0
Non-Federal Obligation
$8.5M
Total Obligated
Activity Timeline
Subgrant Awards
Disclosed subgrants for U24HG006620
Transaction History
Modifications to U24HG006620
Additional Detail
Award ID FAIN
U24HG006620
SAI Number
U24HG006620-331936327
Award ID URI
SAI UNAVAILABLE
Awardee Classifications
Other
Awarding Office
75N400 NIH National Human Genome Research Institute
Funding Office
75N400 NIH National Human Genome Research Institute
Awardee UEI
NPM2J7MSCF61
Awardee CAGE
7A720
Performance District
PA-15
Senators
Robert Casey
John Fetterman
John Fetterman
Budget Funding
Federal Account | Budget Subfunction | Object Class | Total | Percentage |
---|---|---|---|---|
National Human Genome Research Institute, National Institutes of Health, Health and Human Services (075-0891) | Health research and training | Grants, subsidies, and contributions (41.0) | $3,729,224 | 100% |
Modified: 5/5/25